Page 76 - Read Online

Sabaté. Vessel Plus 2022;6:27 Vessel Plus
DOI: 10.20517/2574-1209.2021.135

Editorial Open Access

Current status and future prospects of percutaneous

treatment of mitral valve disease: repair vs.
replacement

Manel Sabaté

Interventional Cardiology Unit, Cardiovascular Institute, Hospital Clinic, University of Barcelona, Barcelona 08036, Spain.
Correspondence to: Prof. Manel Sabaté, Interventional Cardiology Unit, Cardiovascular Institute, Hospital Clinic, University of
Barcelona, C/Villarroel 170, Barcelona 08036, Spain. E-mail: masabate@clinic.cat
How to cite this article: Sabaté M. Current status and future prospects of percutaneous treatment of mitral valve disease: repair
vs. replacement. Vessel Plus 2022;6:27. https://dx.doi.org/10.20517/2574-1209.2021.135
Received: 9 Nov 2021 Accepted: 10 Nov 2021 Published: 13 May 2022

Academic Editor: Alexander D. Verin Copy Editor: Xi-Jun Chen Production Editor: Xi-Jun Chen

After a hesitant start, transcatheter treatment of mitral valve disease is now rapidly evolving. Technical
advancements have made percutaneous treatment a reality. While edge-to-edge repair is a consolidated
procedure with demonstrated clinical efficacy, development of percutaneous mitral valves is relatively more
cumbersome. In this special issue, we have selected five interesting papers that will shed light on this topic.
Cepas-Guillen et al. reviewed current techniques to repair (e.g., leaflet repair, annuloplasty systems, and
[1]
chordae repair) or replace mitral valve (e.g., percutaneous prothesis) in the context of severe regurgitation.
Scotti et al. described the clinical, anatomical, and technical factors in selecting patients for either valve
[2]
repair or replacement procedure. Furthermore, the authors provided with a practical algorithm to help in
[3]
the selection process of different techniques. Spieker et al. demonstrated the benefit of edge-to-edge repair
in patients in whom the handgrip manoeuvre unmasked a severe mitral regurgitation.
Echarte-Morales et al. reviewed the different techniques used to treat mitral regurgitation following failed
[4]
surgical valve repair or replacement.

In this regard, mitral paravalvular leak closure and percutaneous mitral valve-in-valve procedures were
presented. Finally, Nappi et al. focused on emerging transcatheter mitral valve replacement devices as
[5]
therapeutic options for degenerated mitral bioprosthesis or failed mitral repair. In that paper the authors
summarized current interventional techniques and available evidence and compared outcomes between

© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made.

www.vpjournal.net